serine has been researched along with docetaxel anhydrous in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coleman, RL; Gershenson, DM; Han, LY; Jennings, N; Kamat, AA; Kim, TJ; Kundra, V; Landen, CN; Langley, R; Lin, YG; Lu, C; Merritt, WM; Ravoori, M; Sood, AK; Spannuth, WA | 1 |
| Dieras, V; Eskens, FA; Fontaine, H; Hospitel, M; Oprea, C; Tosi, D; Tresca, P; Van der Gaast, A; Van Doorn, L; Veyrat-Follet, C | 1 |
| Bahleda, R; Capri, G; Daglish, B; Del Conte, G; Gianni, L; Hospitel, M; Oprea, C; Sessa, C; Soria, JC; Varga, A | 1 |
| Ecstein-Fraisse, E; Hida, T; Horiike, A; Horio, Y; Nishio, M; Satouchi, M; Sunaga, Y | 1 |
| Becker, KA; Bieberich, E; Bielawski, J; Doolen, S; Goins, L; Gulbins, E; McQuerry, KJ; Spassieva, SD; Sure, U; Taylor, BK; Uerschels, AK | 1 |
3 trial(s) available for serine and docetaxel anhydrous
| Article | Year |
|---|---|
A phase I pharmacokinetic study of the vascular disrupting agent ombrabulin (AVE8062) and docetaxel in advanced solid tumours.
Topics: Adolescent; Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Interactions; Female; Humans; Male; Middle Aged; Neoplasms; Serine; Taxoids; Treatment Outcome; Young Adult | 2014 |
Phase I clinical and pharmacokinetic study of ombrabulin (AVE8062) combined with cisplatin/docetaxel or carboplatin/paclitaxel in patients with advanced solid tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Docetaxel; Drug Interactions; Female; Humans; Male; Middle Aged; Neoplasms; Paclitaxel; Response Evaluation Criteria in Solid Tumors; Serine; Taxoids; Young Adult | 2014 |
Phase 1 study of ombrabulin in combination with docetaxel and cisplatin in Japanese patients with advanced solid tumors.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asian People; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Serine; Taxoids; Treatment Outcome | 2018 |
2 other study(ies) available for serine and docetaxel anhydrous
| Article | Year |
|---|---|
Antitumor and antivascular effects of AVE8062 in ovarian carcinoma.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cell Growth Processes; Cell Line, Tumor; Docetaxel; Female; Fluorodeoxyglucose F18; G2 Phase; Humans; Mice; Mice, Nude; Neovascularization, Pathologic; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Serine; Taxoids; Xenograft Model Antitumor Assays | 2007 |
Role of 1-Deoxysphingolipids in docetaxel neurotoxicity.
Topics: Animals; Antineoplastic Agents, Phytogenic; Axons; Ceramides; Docetaxel; Female; Ganglia, Spinal; Lipids; Lysophospholipids; Mice; Mice, Inbred C57BL; Neurotoxicity Syndromes; Sensory Receptor Cells; Serine; Serine C-Palmitoyltransferase; Sphingolipids; Sphingosine | 2020 |